NuvOx Therapeutics, Inc. (NUOX)

NuvOx Therapeutics Statistics

Total Valuation

NUOX has a market cap or net worth of $91.67 million. The enterprise value is $119.28 million.

Market Cap	91.67M
Enterprise Value	119.28M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

NUOX has 13.10 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	13.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	88.57
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	115.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	0.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-907.38

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$115,000
Profits Per Employee	-$1.31M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NUOX had revenue of $1.04 million and -$11.81 million in losses. Loss per share was -$0.90.

Revenue	1.04M
Gross Profit	1.04M
Operating Income	-4.46M
Pretax Income	-11.81M
Net Income	-11.81M
EBITDA	-11.68M
EBIT	-11.80M
Loss Per Share	-$0.90

Balance Sheet

The company has $266,000 in cash and $27.88 million in debt, with a net cash position of -$27.61 million or -$2.11 per share.

Cash & Cash Equivalents	266,000
Total Debt	27.88M
Net Cash	-27.61M
Net Cash Per Share	-$2.11
Equity (Book Value)	-32.16M
Book Value Per Share	-2.46
Working Capital	-4.53M

Cash Flow

Operating Cash Flow	-1.78M
Capital Expenditures	n/a
Depreciation & Amortization	116,000
Net Borrowing	n/a
Free Cash Flow	-1.78M
FCF Per Share	-$0.14

Margins

Gross margin is 100.00%, with operating and profit margins of -430.53% and -1,140.97%.

Gross Margin	100.00%
Operating Margin	-430.53%
Pretax Margin	-1,140.97%
Profit Margin	-1,140.97%
EBITDA Margin	-1,128.50%
EBIT Margin	-1,139.71%
FCF Margin	-171.88%

Dividends & Yields

NUOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.88%
FCF Yield	-1.94%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a

Data Source: SEC filings Last updated: Jul 24, 2026

The statistics on this page were gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error